TP53 and colorectal cancer: In contrast, in 50% of colorectal cancers, mutations in the p53 gene have been identified [206] which lead to inactivation of p53, and due to this lack of function of p53 it has been observed that tumors with mutant p53 are more chemotherapy-resistant than those with wild-type p53 [207].